Silencing of the glucocorticoid-induced leucine zipper improves the immunogenicity of clinical-grade dendritic cells

Cytotherapy

Volumn 15, Issue 6, 2013, Pages 740-749

  Cathelin, Dominique ^a,b   Met, Özcan ^a   Svane, Inge Marie ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b HÔPITAL TENON   (France)

Author keywords

dendritic cells; electroporation; GILZ; immunotherapy; siRNA

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID INDUCED LEUCINE ZIPPER PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; LEUCINE ZIPPER PROTEIN; PROGRAMMED DEATH 1 LIGAND 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ELECTROPORATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOGENICITY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

CELL DIFFERENTIATION; DENDRITIC CELLS; DINOPROSTONE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCOCORTICOIDS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUCINE ZIPPERS; LEUKOCYTES, MONONUCLEAR; RNA, SMALL INTERFERING; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877309739     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.02.005     Document Type: Article

References (39)

1. D.M. Andrews, E. Maraskovsky, and M.J. Smyth Cancer vaccines for established cancer: how to make them better? Immunol Rev 222 2008 242 255
2. F.O. Nestle, S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, and R. Dummer Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nat Med 4 1998 328 332
3. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
4. C.M. Hilkens, P. Kalinski, M. de Boer, and M.L. Kapsenberg Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype Blood 90 1997 1920 1926
5. A. Chakraborty, L. Li, N.G. Chakraborty, and B. Mukherji Stimulatory and inhibitory maturation of human macrophage-derived dendritic cells Pathobiology 67 1999 282
6. A. Chakraborty, L. Li, N.G. Chakraborty, and B. Mukherji Stimulatory and inhibitory differentiation of human myeloid dendritic cells Clin Immunol 94 2000 88
7. S. Corinti, C. Albanesi, A. la Sala, S. Pastore, and G. Girolomoni Regulatory activity of autocrine IL-10 on dendritic cell functions J Immunol 166 2001 4312 4318
8. R. Maldonado-López, and M. Moser Dendritic cell subsets and the regulation of Th1/Th2 responses Semin Immunol 13 2001 275
9. F. Willems, A. Marchant, J.P. Delville, C. Gérard, A. Delvaux, and T. Velu Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes Eur J Immunol 24 1994 1007 1009
10. T. De Smedt, M. Van Mechelen, G. De Becker, J. Urbain, O. Leo, and M. Moser Effect of interleukin-10 on dendritic cell maturation and function Eur J Immunol 27 1997 1229 1235
11. C.-P. Mao, C.-F. Hung, and T.C. Wu Immunotherapeutic strategies employing RNA interference technology for the control of cancers J Biomed Sci 14 2007 15
12. L. Lebson, T. Wang, Q. Jiang, and K.A. Whartenby Induction of the glucocorticoid-induced leucine zipper gene limits the efficacy of dendritic cell vaccines Cancer Gene Ther 18 2011 563 570
13. F. D'Adamio, O. Zollo, R. Moraca, E. Ayroldi, S. Bruscoli, and A. Bartoli A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death Immunity 7 1997 803 812
14. E. Ayroldi, G. Migliorati, S. Bruscoli, C. Marchetti, O. Zollo, and L. Cannarile Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor {kappa}B Blood 98 2001 743 753
15. P.R. Mittelstadt, and J.D. Ashwell Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ J Biol Chem 276 2001 29603 29610
16. M.-L. Asselin-Labat, M. David, A. Biola-Vidamment, D. Lecoeuche, M.-C. Zennaro, and J. Bertoglio GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis Blood 104 2004 215 223
17. L. Cannarile, S. Cuzzocrea, L. Santucci, M. Agostini, E. Mazzon, and E. Esposito Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis Gastroenterology 136 2009 530 541
18. L. Cannarile, F. Fallarino, M. Agostini, S. Cuzzocrea, E. Mazzon, and C. Vacca Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines Blood 107 2006 1039 1047
19. R. Glynne, G. Ghandour, J. Rayner, D.H. Mack, and C.C. Goodnow B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays Immunol Rev 176 2000 216 246
20. D. Berrebi, S. Bruscoli, N. Cohen, A. Foussat, G. Migliorati, and L. Bouchet-Delbos Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10 Blood 101 2003 729 738
21. L. Cannarile, O. Zollo, F. D'Adamio, E. Ayroldi, C. Marchetti, and A. Tabilio Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene Cell Death Differ 8 2001 201 203
22. N. Cohen, E. Mouly, H. Hamdi, M.-C. Maillot, M. Pallardy, and V. Godot GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response Blood 107 2006 2037 2044
23. K.W. Moore, R. de Waal Malefyt, R.L. Coffman, and A. O'Garra Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 2001 683 765
24. F. Sallusto, and A. Lanzavecchia Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha J Exp Med 179 1994 1109 1118
25. R. Trepiakas, A.E. Pedersen, Ö. Met, M.H. Hansen, A. Berntsen, and I.M. Svane Comparison of [alpha]-type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients Vaccine 26 2008 2824 2832
26. B. Seliger, F.M. Marincola, S. Ferrone, and H. Abken The complex role of B7 molecules in tumor immunology Trends Mol Med 14 2008 550 559
27. E. Ayroldi, and C. Riccardi Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action FASEB J 23 2009 3649 3658
28. J.R. Currier, E.G. Kuta, E. Turk, L.B. Earhart, L. Loomis-Price, and S. Janetzki A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays J Immunol Methods 260 2002 157 172
29. H.A. Haenssle, S.W. Krause, S. Emmert, M. Zutt, L. Kretschmer, and H. Schmidberger Hybrid cell vaccination in metastatic melanoma: clinical and immunologic results of a phase I/II study J Immunother 27 2004 147 155
30. Ö. Met, J. Eriksen, and I. Svane Studies on mRNA electroporation of immature and mature dendritic cells: effects on their immunogenic potential Mol Biotechnol 40 2008 151
31. Ö. Met, E. Balslev, H. Flyger, and I. Svane High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer Breast Cancer Res Treat 125 2011 395 406
32. A.T. Prechtel, N.M. Turza, A.A. Theodoridis, M. Kummer, and A. Steinkasserer Small interfering RNA (siRNA) delivery into monocyte-derived dendritic cells by electroporation J Immunol Methods 311 2006 139 152
33. X. Cao, K. Leonard, L.I. Collins, S.F. Cai, J.C. Mayer, and J.E. Payton Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance Cancer Res 69 2009 8700 8709
34. F.M. Ayres, M. Narita, M. Takahashi, T. Yano, A. Liu, and K. Toba Human dendritic cells mediate anti-tumor activity against hematopoietic tumor cells without direct contact and Fas/FasL killing pathway Oncol Rep 11 2004 1017 1023
35. F. Koch, U. Stanzl, P. Jennewein, K. Janke, C. Heufler, and E. Kämpgen High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 J Exp Med 184 1996 741 746
36. A. Ribas, J.A. Glaspy, Y. Lee, V.B. Dissette, E. Seja, and H.T. Vu Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy J Immunother (1997) 27 2004 354 367
37. M.E. Keir, L.M. Francisco, and A.H. Sharpe PD-1 and its ligands in T-cell immunity Curr Opin Immunol 19 2007 309 314
38. Y. Latchman, C.R. Wood, T. Chernova, D. Chaudhary, M. Borde, and I. Chernova PD-L2 is a second ligand for PD-1 and inhibits T cell activation Nat Immunol 2 2001 261 268
39. A.E. Pedersen, M. Thorn, M. Gad, M.R. Walter, H.E. Johnsen, and E. Gaarsdal Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination Scand J Immunol 61 2005 147 156